Inc. (NASDAQ:INCR) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security
Holders.
On June29, 2017, Monogram Residential Trust,Inc. (the Company)
held its 2017 annual meeting of stockholders (the Annual Meeting)
in Plano, Texas. At the Annual Meeting, the Companys stockholders
voted in person or by proxy on (1)the election of seven directors
to serve until the 2018 annual meeting of stockholders and until
their successors are elected and qualified, (2)a non-binding,
advisory vote on the compensation of the Companys named executive
officers, and (3)the ratification of the appointment of Deloitte
Touche LLP as the Companys independent registered public
accounting firm for the year ending December31, 2017. The results
of the voting were as follows:
1. The following directors were elected to serve on the board of
directors until the 2018 annual meeting of stockholders and until
their respective successors are duly elected and qualified.
|
Name |
|
VotesFor |
|
VotesWithheld |
|
BrokerNon-Votes |
|
Mark T. Alfieri |
116,376,524 |
1,411,350 |
35,113,376 |
|||
|
David D. Fitch |
105,007,762 |
12,780,112 |
35,113,376 |
|||
|
Tammy K. Jones |
105,047,422 |
12,740,452 |
35,113,376 |
|||
|
Jonathan L. Kempner |
104,536,895 |
13,250,979 |
35,113,376 |
|||
|
W. Benjamin Moreland |
112,901,645 |
4,886,229 |
35,113,376 |
|||
|
E. Alan Patton |
116,313,530 |
1,474,344 |
35,113,376 |
|||
|
Timothy J. Pire |
105,029,922 |
12,757,952 |
35,113,376 |
2. The Companys stockholders approved, on a non-binding advisory
basis, the compensation of the Companys named executive officers
as follows:
|
VotesFor |
|
Against |
|
Abstain |
|
BrokerNon-Votes |
|
|
114,160,176 |
2,503,569 |
1,124,129 |
35,113,376 |
3. The Companys stockholders ratified the appointment of Deloitte
Touche LLP as the Companys independent registered public
accounting firm for the fiscal year ending December31, 2017 as
follows:
|
VotesFor |
|
Against |
|
Abstain |
|
|
151,579,649 |
346,632 |
974,969 |
Item 8.01. Other Events.
In connection with the Annual Meeting and effective June29,
2017, the Companys board of directors, based on the
recommendations of the nominating and corporate governance
committee, made the following appointments:
Audit Committee
Timothy J. Pire, Chairman
Tammy K. Jones
W. Benjamin Moreland
E. Alan Patton
Compensation Committee
David D. Fitch, Chairman
Jonathan L. Kempner
W. Benjamin Moreland
Timothy J. Pire
Nominating and Corporate Governance
Committee
Jonathan L. Kempner, Chairman
David D. Fitch
Tammy K. Jones
Timothy J. Pire
About Inc. (NASDAQ:INCR)
INC Research Holdings, Inc. is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company’s Clinical Development Services segment offers all clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Company’s Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.